UK markets open in 6 hours 17 minutes

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.25-0.69 (-4.95%)
At close: 04:00PM EDT
13.25 0.00 (0.00%)
After hours: 04:16PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts19191919
Avg. Estimate-1.68-1.6-6.59-5.14
Low estimate-2.04-1.9-7.36-7.53
High estimate-1.17-0.99-4.953.59
Year ago EPS-2.68-3.37-9.05-6.59
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts19191919
Avg. Estimate9.34M11.75M43.64M130.9M
Low estimate6.54M7.5M31.77M51.08M
High estimate13.9M17.9M59.9M584.56M
Year ago sales2.47M2.72M86.45M43.64M
Sales growth (year/est)278.10%332.60%-49.50%200.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.55-2.73-1.28-1.65
Actual EPS-2.68-3.37-0.55-1.8
Difference-0.13-0.640.73-0.15
Surprise %-5.10%-23.40%57.00%-9.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.68-1.6-6.59-5.14
7 days ago-1.67-1.61-6.51-4.88
30 days ago-1.6-1.58-6.25-4.73
60 days ago-1.58-1.57-6.22-4.76
90 days ago-1.74-1.7-6.1-5.24
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2212
Up last 30 days5857
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1125
Growth estimatesSAGEIndustrySector(s)S&P 500
Current qtr.37.30%N/AN/AN/A
Next qtr.52.50%N/AN/AN/A
Current year27.20%N/AN/AN/A
Next year22.00%N/AN/AN/A
Next 5 years (per annum)16.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A